These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10974201)

  • 1. Inhibition of HIV-1 protease by a boron-modified polypeptide.
    Pivazyan AD; Matteson DS; Fabry-Asztalos L; Singh RP; Lin PF; Blair W; Guo K; Robinson B; Prusoff WH
    Biochem Pharmacol; 2000 Oct; 60(7):927-36. PubMed ID: 10974201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance.
    Kozísek M; Cígler P; Lepsík M; Fanfrlík J; Rezácová P; Brynda J; Pokorná J; Plesek J; Grüner B; Grantz Sasková K; Václavíková J; Král V; Konvalinka J
    J Med Chem; 2008 Aug; 51(15):4839-43. PubMed ID: 18598016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease.
    Davis DA; Brown CA; Singer KE; Wang V; Kaufman J; Stahl SJ; Wingfield P; Maeda K; Harada S; Yoshimura K; Kosalaraksa P; Mitsuya H; Yarchoan R
    Antiviral Res; 2006 Nov; 72(2):89-99. PubMed ID: 16687179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of HIV-1 protease by interface peptides.
    Schramm HJ; Billich A; Jaeger E; Rücknagel KP; Arnold G; Schramm W
    Biochem Biophys Res Commun; 1993 Jul; 194(2):595-600. PubMed ID: 8343146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes.
    Rezácová P; Pokorná J; Brynda J; Kozísek M; Cígler P; Lepsík M; Fanfrlík J; Rezác J; Grantz Sasková K; Sieglová I; Plesek J; Sícha V; Grüner B; Oberwinkler H; Sedlácek' J; Kräusslich HG; Hobza P; Král V; Konvalinka J
    J Med Chem; 2009 Nov; 52(22):7132-41. PubMed ID: 19874035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of human immunodeficiency virus proteases by 'interface peptides'.
    Schramm HJ; Boetzel J; Büttner J; Fritsche E; Göhring W; Jaeger E; König S; Thumfart O; Wenger T; Nagel NE; Schramm W
    Antiviral Res; 1996 May; 30(2-3):155-70. PubMed ID: 8783807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentacycloundecane derived hydroxy acid peptides: a new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease inhibitors.
    Karpoormath R; Sayed Y; Govender P; Govender T; Kruger HG; Soliman MES; Maguire GEM
    Bioorg Chem; 2012 Feb; 40(1):19-29. PubMed ID: 21982718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and activity of N-benzyl pseudopeptides HIV protease inhibitors.
    Marastoni M; Bazzaro M; Bortolotti F; Tomatis R
    Bioorg Med Chem; 2003 May; 11(11):2477-83. PubMed ID: 12735995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the stereochemical requirements for protease inhibition by ureidopeptides.
    Barth BS; Myers AC; Lipton MA
    J Pept Res; 2005 Mar; 65(3):352-4. PubMed ID: 15787965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sidechain-linked inhibitors of HIV-1 protease dimerization.
    Bowman MJ; Chmielewski J
    Bioorg Med Chem; 2009 Feb; 17(3):967-76. PubMed ID: 18337105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, 2D-NMR and molecular modelling studies of pentacycloundecane lactam-peptides and peptoids as potential HIV-1 wild type C-SA protease inhibitors.
    Makatini MM; Petzold K; Alves CN; Arvidsson PI; Honarparvar B; Govender P; Govender T; Kruger HG; Sayed Y; JerônimoLameira ; Maguire GE; Soliman ME
    J Enzyme Inhib Med Chem; 2013 Feb; 28(1):78-88. PubMed ID: 22339087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
    Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
    J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease.
    Louis JM; Dyda F; Nashed NT; Kimmel AR; Davies DR
    Biochemistry; 1998 Feb; 37(8):2105-10. PubMed ID: 9485357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel strategies for targeting the dimerization interface of HIV protease with cross-linked interfacial peptides.
    Bowman MJ; Chmielewski J
    Biopolymers; 2002; 66(2):126-33. PubMed ID: 12325162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule dimerization inhibitors of wild-type and mutant HIV protease: a focused library approach.
    Shultz MD; Ham YW; Lee SG; Davis DA; Brown C; Chmielewski J
    J Am Chem Soc; 2004 Aug; 126(32):9886-7. PubMed ID: 15303839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triterpenes as potential dimerization inhibitors of HIV-1 protease.
    Quéré L; Wenger T; Schramm HJ
    Biochem Biophys Res Commun; 1996 Oct; 227(2):484-8. PubMed ID: 8967903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of new inhibitors of HIV-1 protease dimerization with conformationally constrained templates.
    Song M; Rajesh S; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2465-8. PubMed ID: 11549448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of inhibitor binding to feline and human immunodeficiency virus proteases: structure-based drug design and the resistance problem.
    Dunn BM; Pennington MW; Frase DC; Nash K
    Biopolymers; 1999; 51(1):69-77. PubMed ID: 10380354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance.
    Ghosh AK; Chapsal BD; Weber IT; Mitsuya H
    Acc Chem Res; 2008 Jan; 41(1):78-86. PubMed ID: 17722874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.
    Beck ZQ; Hervio L; Dawson PE; Elder JH; Madison EL
    Virology; 2000 Sep; 274(2):391-401. PubMed ID: 10964781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.